195 related articles for article (PubMed ID: 24972818)
1. Low signal intensity in U-fiber identified by susceptibility-weighted imaging in two cases of progressive multifocal leukoencephalopathy.
Miyagawa M; Maeda M; Umino M; Kagawa K; Nakamichi K; Sakuma H; Tomimoto H
J Neurol Sci; 2014 Sep; 344(1-2):198-202. PubMed ID: 24972818
[TBL] [Abstract][Full Text] [Related]
2. Low-signal-intensity rim on susceptibility-weighted imaging is not a specific finding to progressive multifocal leukoencephalopathy.
Umino M; Maeda M; Ii Y; Tomimoto H; Sakuma H
J Neurol Sci; 2016 Mar; 362():155-9. PubMed ID: 26944139
[TBL] [Abstract][Full Text] [Related]
3. Conventional and diffusion-weighted MRI in progressive multifocal leukoencephalopathy: new elements for identification and follow-up.
da Pozzo S; Manara R; Tonello S; Carollo C
Radiol Med; 2006 Oct; 111(7):971-7. PubMed ID: 17021685
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility-Weighted MR Imaging Hypointense Rim in Progressive Multifocal Leukoencephalopathy: The End Point of Neuroinflammation and a Potential Outcome Predictor.
Thurnher MM; Boban J; Rieger A; Gelpi E
AJNR Am J Neuroradiol; 2019 Jun; 40(6):994-1000. PubMed ID: 31122919
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy.
Yousry TA; Pelletier D; Cadavid D; Gass A; Richert ND; Radue EW; Filippi M
Ann Neurol; 2012 Nov; 72(5):779-87. PubMed ID: 23280794
[TBL] [Abstract][Full Text] [Related]
6. Use of quantitative susceptibility mapping (QSM) in progressive multifocal leukoencephalopathy.
Carra-Dalliere C; Menjot de Champfleur N; Deverdun J; Ayrignac X; Nerrant E; Makinson A; Casanova ML; Labauge P
J Neuroradiol; 2016 Feb; 43(1):6-10. PubMed ID: 26475668
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy using MRI.
Wattjes MP; Barkhof F
Curr Opin Neurol; 2014 Jun; 27(3):260-70. PubMed ID: 24739400
[TBL] [Abstract][Full Text] [Related]
8. Cortical hypointensity in T2-weighted gradient-echo sequences in patients with progressive multifocal leukoencephalopathy.
López Sala P; Alberdi Aldasoro N; Zelaya Huerta MV; Bacaicoa Saralegui MC; Cabada Giadás T
Radiologia (Engl Ed); 2020; 62(1):59-66. PubMed ID: 31375267
[TBL] [Abstract][Full Text] [Related]
9. Pomalidomide-associated progressive multifocal leukoencephalopathy in multiple myeloma: cortical susceptibility-weighted imaging hypointense findings prior to clinical deterioration.
Ueno H; Kikumto M; Takebayashi Y; Ishibashi H; Takahashi T; Yasutomi H; Umemoto K; Nakamichi K; Saijo M; Ichinohe T; Maruyama H
J Neurovirol; 2020 Jun; 26(3):452-455. PubMed ID: 32394398
[TBL] [Abstract][Full Text] [Related]
10. [An autopsy case of progressive multifocal leukoencephalopathy: comparison of magnetic resonance imaging findings with the pathological findings].
Iida M; Kawakami O; Ando T; Yoshida M; Hashizume Y; Hayakawa S
Brain Nerve; 2011 Sep; 63(9):1001-7. PubMed ID: 21878703
[TBL] [Abstract][Full Text] [Related]
11. Progressive multifocal leukoencephalopathy and relapsing-remitting multiple sclerosis: a comparative study.
Boster A; Hreha S; Berger JR; Bao F; Penmesta R; Tselis A; Endress C; Zak I; Perumal J; Caon C; Vazquez J; Tyler KL; Racke MK; Millis S; Khan O
Arch Neurol; 2009 May; 66(5):593-9. PubMed ID: 19433659
[TBL] [Abstract][Full Text] [Related]
12. High b-value diffusion-weighted imaging in progressive multifocal leukoencephalopathy in HIV patients.
Godi C; De Vita E; Tombetti E; Davagnanam I; Haddow L; Jäger HR
Eur Radiol; 2017 Sep; 27(9):3593-3599. PubMed ID: 28168372
[TBL] [Abstract][Full Text] [Related]
13. Progressive multifocal leukoencephalopathy: value of diffusion-weighted and contrast-enhanced magnetic resonance imaging for diagnosis and treatment control.
Küker W; Mader I; Nägele T; Uhl M; Adolph C; Klose U; Herrlinger U
Eur J Neurol; 2006 Aug; 13(8):819-26. PubMed ID: 16879291
[TBL] [Abstract][Full Text] [Related]
14. The chameleon of neuroinflammation: magnetic resonance imaging characteristics of natalizumab-associated progressive multifocal leukoencephalopathy.
Wattjes MP; Richert ND; Killestein J; de Vos M; Sanchez E; Snaebjornsson P; Cadavid D; Barkhof F
Mult Scler; 2013 Dec; 19(14):1826-40. PubMed ID: 24192217
[TBL] [Abstract][Full Text] [Related]
15. Development of demyelinating lesions in progressive multifocal leukoencephalopathy (PML): Comparison of magnetic resonance images and neuropathology of post-mortem brain.
Ono D; Shishido-Hara Y; Mizutani S; Mori Y; Ichinose K; Watanabe M; Tanizawa T; Yokota T; Uchihara T; Fujigasaki H
Neuropathology; 2019 Aug; 39(4):294-306. PubMed ID: 31155757
[TBL] [Abstract][Full Text] [Related]
16. A role for susceptibility weighted imaging in progressive multifocal leukoencephalopathy.
Yap SM; Murray B; Lynch T; Kavanagh E; MacMahon P
Ir Med J; 2017 Apr; 110(4):549. PubMed ID: 28665088
[TBL] [Abstract][Full Text] [Related]
17. Juxtacortical susceptibility changes in progressive multifocal leukoencephalopathy at the gray-white matter junction correlates with iron-enriched macrophages.
Mahajan KR; Amin M; Poturalski M; Lee J; Herman D; Zheng Y; Androjna C; Howell M; Fox RJ; Trapp BD; Jones SE; Nakamura K; Ontaneda D
Mult Scler; 2021 Dec; 27(14):2159-2169. PubMed ID: 33749379
[TBL] [Abstract][Full Text] [Related]
18. Progressive multifocal leukoencephalopathy and human immunodeficiency virus-associated white matter lesions in AIDS: magnetization transfer MR imaging.
Ernst T; Chang L; Witt M; Walot I; Aronow H; Leonido-Yee M; Singer E
Radiology; 1999 Feb; 210(2):539-43. PubMed ID: 10207441
[TBL] [Abstract][Full Text] [Related]
19. [Progressive multifocal leukoencephalopathy in AIDS].
Enting RH; Portegies P; Algra PR; Valk J; Lange JM
Ned Tijdschr Geneeskd; 1992 Mar; 136(11):521-6. PubMed ID: 1552955
[TBL] [Abstract][Full Text] [Related]
20. Atypical progressive multifocal leukoencephalopathy in HIV with a high CD4 count: the use of magnetic resonance imaging plus spectrometry studies.
Manfredi R; Piergentili B; Marinacci G; Calza L
Int J STD AIDS; 2012 Mar; 23(3):e35-8. PubMed ID: 22581894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
